Bernstein Upgrades The Cigna Group (CI) From “Market Perform” To “Outperform”

Why It Matters

The rating lift signals heightened investor confidence in Cigna’s earnings trajectory and positions the stock as a compelling buy in the health‑services sector, potentially attracting capital inflows.

Key Takeaways

• Bernstein raises Cigna rating to Outperform
• $358 price target reflects PBM reform benefits
• EPS estimates lifted for 2027‑2030
• Evernorth and Healthcare income targets reaffirmed
• New CEO Brian Evanko gains analyst confidence

Pulse Analysis

Cigna’s recent upgrade by Bernstein comes at a pivotal moment for the health‑services giant. The firm’s analysts cite the upcoming Pharmacy Benefit Manager reform bill and a recent FTC settlement as catalysts that could improve profit margins across its PBM operations. Coupled with Cigna’s own announced shifts toward a more integrated PBM model, these regulatory and strategic developments are expected to boost the company’s valuation multiple, prompting Bernstein to move the rating to Outperform and set a $358 price target.

Financially, Bernstein’s modest raise in EPS estimates for 2027‑2030 reflects confidence that the cost efficiencies from PBM reforms will translate into higher earnings. Cigna’s guidance for 2026—at least $30.25 per share in adjusted income—remains unchanged, while Evernorth and Cigna Healthcare each reaffirmed robust pre‑tax income thresholds of $6.9 billion and $4.5 billion respectively. These stable forecasts, combined with the upgraded rating, suggest that the market may re‑price Cigna’s shares to reflect anticipated earnings growth and operational resilience.

The leadership transition adds another layer of intrigue. While CEO David Cordani’s retirement surprised analysts, the appointment of Brian Evanko has been well‑received, with JPMorgan analysts expressing confidence in his ability to steer the company through regulatory changes and competitive pressures. This leadership continuity, paired with favorable policy headwinds, positions Cigna to capitalize on expanding demand for integrated health solutions, making it a focal point for investors seeking exposure to the evolving healthcare landscape.